Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators

Research output: Contribution to journalArticlepeer-review

393 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences